Stay updated on PB-USTE Efficacy & Safety in Bullous Pemphigoid Clinical Trial
Sign up to get notified when there's something new on the PB-USTE Efficacy & Safety in Bullous Pemphigoid Clinical Trial page.

Latest updates to the PB-USTE Efficacy & Safety in Bullous Pemphigoid Clinical Trial page
- Check2 days agoChange DetectedThe study record for the ustekinumab trial is now displayed, with details on its completed Phase 2 design, treatment, participant criteria, and remission outcome. The prior access-denied page is no longer shown.SummaryDifference37%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The page continues to display a 403 error instead of the study record.SummaryDifference0.2%

- Check16 days agoChange DetectedAn NIH banner announces updates and explains that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study record page now shows a 403 Forbidden error, replacing the previous content. The 403 page includes standard site chrome and a basic message indicating access is restricted.SummaryDifference16%

Stay in the know with updates to PB-USTE Efficacy & Safety in Bullous Pemphigoid Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PB-USTE Efficacy & Safety in Bullous Pemphigoid Clinical Trial page.